🦟 MALARIA - Complete Exam-Oriented Clinical Guide

1. DEFINITION

2. CAUSES (ETIOLOGY)

The Five Plasmodium Species

Exam tip: P. falciparum is responsible for almost all malaria deaths. P. knowlesi (Southeast Asia) looks like P. malariae on smear but behaves like falciparum.

Vector

• Only the female Anopheles mosquito transmits malaria
• Humans are the only natural reservoir

Other (Rare) Routes of Transmission

• Blood transfusion
• Needle sharing (IV drug users)
• Organ transplant
• Vertical (mother to fetus - congenital malaria)

Important Risk Factors

Exam pearl: Sickle cell trait, thalassemia, G6PD deficiency, and other red cell defects are most prevalent in malaria-endemic regions because heterozygous states confer protection from severe malaria - a classic example of balanced polymorphism.

3. TYPES / CLASSIFICATION

By Species (Most Clinically Important Classification)

• Fever every 48 hours (but often irregular in practice)
• Invades ALL ages of RBCs → high parasitemia
• Produces PfEMP1 → RBC sequestration in microvasculature
• Only species causing cerebral malaria, blackwater fever, multiorgan failure
• No hypnozoites → no true relapse (but recrudescence occurs)
• Drug resistance is a major problem

• Fever every 48 hours
• Only infect young/reticulocyte RBCs → lower parasitemia
• Contain hypnozoites (dormant liver stage) → TRUE RELAPSE after months/years
• Requires primaquine to eliminate liver stage
• P. ovale: found mainly in West Africa

• Fever every 72 hours ("quartan" = 4-day cycle)
• Infects old RBCs only
• Very chronic, low-grade
• Associated with nephrotic syndrome in children (immune complex deposition)
• No hypnozoites but can persist for decades

• 24-hour fever cycle (quotidian)
• Zoonotic from macaque monkeys in Southeast Asia (Borneo, Malaysia)
• Morphologically mimics P. malariae on blood smear
• Clinically can be severe and fatal

Fever Periodicity Summary

4. PATHOPHYSIOLOGY

Life Cycle Diagram (from Robbins Pathology)

Step-by-Step Pathophysiology Flowchart

Female Anopheles mosquito bites human
           ↓
SPOROZOITES injected into bloodstream
           ↓
Sporozoites travel to LIVER within minutes
(bind via Thrombospondin-related adhesive protein +
 Circumsporozoite protein → Heparan sulfate proteoglycan on hepatocytes)
           ↓
HEPATIC STAGE (clinically silent - 1-4 weeks incubation)
→ Sporozoites → differentiate into MEROZOITES inside hepatocytes
→ [P. vivax / P. ovale only: some form HYPNOZOITES = dormant stage → causes relapse later]
           ↓
Infected hepatocytes RUPTURE → release thousands of MEROZOITES into blood
           ↓
ERYTHROCYTIC STAGE begins (causes all clinical disease)
→ Merozoite surface lectin-like molecule binds GLYCOPHORIN (sialidated)
   on RBC surface → merozoite invaginates into RBC inside a "digestive vacuole"
           ↓
Inside RBC: Merozoite → RING TROPHOZOITE → TROPHOZOITE → SCHIZONT
           ↓
SCHIZONT expresses PfEMP1 (P. falciparum erythrocyte membrane protein 1)
→ PfEMP1 forms KNOBS on RBC surface
→ Knobs bind endothelial adhesion molecules: ICAM-1, VCAM-1, CD36
→ Infected RBCs SEQUESTER in capillary beds (brain, lung, kidney, placenta)
→ This causes CEREBRAL MALARIA, ARDS, renal failure
           ↓
Schizonts → differentiate into MEROZOITES → RBC LYSES (every 48 or 72 hrs)
→ Merozoites released → infect new RBCs (cycle repeats)
→ RBC lysis triggers fever (TNF-α, IL-1, IL-6 release)
→ Hemozoin (brown malarial pigment = hemoglobin breakdown product) released
           ↓
Some trophozoites → GAMETOCYTES → ingested by next mosquito → sexual cycle restarts

Why Each Key Problem Occurs

5. CLINICAL FEATURES

The Classic Malarial Paroxysm (Three Stages)

COLD STAGE (15-60 min)
→ Rigors (violent shaking chills), goose bumps, teeth chattering
→ Temperature RISING
           ↓
HOT STAGE (2-6 hours)
→ High fever (39-41°C / 102-106°F)
→ Flushing, headache, nausea, vomiting, body aches
→ No sweating yet
           ↓
SWEATING STAGE (2-4 hours)
→ Profuse sweating, temperature FALLS
→ Patient feels exhausted but better temporarily
→ Cycle repeats in 48 or 72 hours

Symptoms

Signs

Signs of Severe/Complicated Malaria (P. falciparum)

6. KEY SYMPTOMS THAT SUGGEST THE DIAGNOSIS

Hallmark Symptom

Cyclical paroxysms of chills → fever → profuse sweating in a patient from or traveling to an endemic area.

Classic Clinical Clues

Red Flag Findings (Admit Immediately - Severe Malaria)

• 🚨 Altered consciousness / coma (cerebral malaria)
• 🚨 Respiratory distress (ARDS)
• 🚨 Severe anemia (Hb < 7 g/dL)
• 🚨 Hyperparasitemia (>5% parasitized RBCs)
• 🚨 Hypoglycemia (<2.2 mmol/L)
• 🚨 Blackwater fever (hemoglobinuria)
• 🚨 Circulatory collapse / shock
• 🚨 Acute kidney injury
• 🚨 Abnormal bleeding / DIC
• 🚨 Repeated convulsions

Clinical pearl: In falciparum malaria, peripheral smear may show ONLY ring forms and gametocytes - all other stages are sequestered in deep microvasculature and invisible on blood film. This is why very low parasitemia on smear does NOT rule out severe falciparum malaria.

Protective genetics pearl (from Murray & Nadel): Nearly all genetic RBC defects - sickle cell anemia, thalassemia, pyruvate kinase deficiency, G6PD deficiency - are most prevalent in malaria-endemic regions. Heterozygous sickle cell trait is protective against severe falciparum malaria. This is textbook balanced polymorphism.

Quick Exam Summary Table

7. LABORATORY INVESTIGATIONS OF MALARIA

COMPLETE BLOOD COUNT (CBC)

Exam tip: Thrombocytopenia + normocytic anemia + fever in a traveler = malaria until proven otherwise.

BIOCHEMISTRY

DISEASE-SPECIFIC TESTS

IMAGING FINDINGS

Blood Smear Species Identification Quick Reference

8. DIFFERENTIAL DIAGNOSIS

Key exam principle: In any febrile traveler returning from sub-Saharan Africa or South/Southeast Asia, malaria is the presumptive diagnosis until ruled out by at least three negative blood smears taken 12-24 hours apart. Do not wait for smear results before treating if clinical suspicion is high - P. falciparum kills within days.

9. SHORT CLINICAL CASES

Case 1 - Classic Uncomplicated Malaria

• Travel to high-endemic West Africa (Ghana) + no prophylaxis = classic exposure history
• 48-hour cyclic fever with rigors and sweating = the three-stage malarial paroxysm
• Splenomegaly from RBC destruction and mononuclear phagocyte hyperplasia
• Thrombocytopenia (62,000) + normocytic anemia = hallmark CBC findings
• Elevated indirect bilirubin = hemolytic anemia
• Leukopenia (not leukocytosis) differentiates from bacterial sepsis
• Next step: Thick and thin blood smear (Giemsa) immediately + RDT; IV artesunate or oral ACT (artemether-lumefantrine) without delay

Case 2 - Severe/Cerebral Malaria (Red Flag Case)

• Age < 5-6 years in sub-Saharan Africa = highest-risk group for severe falciparum malaria
• Seizures + coma + fever = cerebral malaria (PfEMP1 knob-mediated sequestration of RBCs in cerebral microvasculature causing ischemia + inflammation)
• Banana-shaped (crescent) gametocytes on smear = pathognomonic for P. falciparum
• Hyperparasitemia >5% = WHO severity criterion
• Severe anemia (Hb 5.1) = immediate transfusion territory
• Hypoglycemia (1.8 mmol/L) = parasite glucose consumption + quinine-stimulated insulin; explain the seizures and coma
• Next step: IV artesunate IMMEDIATELY (first-line for severe falciparum per WHO 2023 guidelines); IV dextrose for hypoglycemia; blood transfusion; airway protection; do NOT delay treatment for confirmatory tests

Exam memory hook: "The 3 H's of severe falciparum malaria" = Hypoglycemia + Hyperparasitemia + Hemolysis (anemia) + one bonus - Headache progressing to coma (cerebral malaria).

10. TREATMENT OF MALARIA

A. NON-PHARMACOLOGICAL TREATMENT

Adjunctive treatments that are NOT recommended (per Harrison's): High-dose corticosteroids, heparin, dextran, urea, desferrioxamine, anti-TNF antibody - all have been studied and found ineffective or harmful in severe malaria. Do NOT use steroids in cerebral malaria.

B. PHARMACOLOGICAL TREATMENT

DRUG PRIORITY LEGEND

• 🥇 DOC / First-line
• 🥈 Alternative / Second-line
• 🚨 Emergency / Parenteral
• 🌿 Radical cure (anti-relapse)

PART 1: UNCOMPLICATED MALARIA

Chloroquine-Resistant / Unknown Resistance Areas (Most of the World)

Chloroquine-Sensitive Areas Only (Central America, Caribbean, parts of Middle East)

Radical Cure - Eliminating Hypnozoites (P. vivax and P. ovale ONLY)

PART 2: SEVERE / COMPLICATED MALARIA

Principle: IV artesunate is superior to quinine - reduces mortality by 35% in Asian adults and 22.5% in African children vs. quinine (Harrison's). It is now the WHO gold-standard for severe malaria.

After parenteral treatment: Switch to full course of oral ACT (artemether-lumefantrine or atovaquone-proguanil) as soon as patient can swallow. Add primaquine/tafenoquine if P. vivax or P. ovale (after G6PD check).

PART 3: CHEMOPROPHYLAXIS FOR TRAVELERS

11. CLINICAL PEARLS

Bedside Clues

• Periodic spiking fever + chills + sweating + thrombocytopenia in any patient with tropical travel history = malaria until proven otherwise. Order the smear before any other test.
• In early P. falciparum malaria, fever is often continuous and irregular - the classic 48-hour cycle develops later. Don't be misled into ruling out malaria because the fever isn't cyclic yet.
• A patient returning from West Africa with "flu-like illness" has malaria until 3 negative smears prove otherwise. The most common missed diagnosis in returning travelers is malaria misdiagnosed as influenza or viral fever.
• Splenomegaly + thrombocytopenia is the classic pairing. If spleen is palpable and platelets are low in a febrile patient - think malaria first.
• Splenic rupture warning: Any patient with malaria who develops sudden, severe left upper quadrant pain with hemodynamic instability has a ruptured spleen (most common with P. vivax). Surgical emergency.

High-Yield Exam Facts

• P. falciparum is the ONLY species with banana/crescent-shaped gametocytes → pathognomonic on blood smear.
• P. vivax and P. ovale have Schüffner's dots in enlarged RBCs.
• P. malariae has band-form (ribbon-form) trophozoites and infects only old RBCs → lowest parasitemia.
• Blackwater fever = massive hemolysis + hemoglobinuria + AKI - exclusive to P. falciparum (or quinine-induced hemolysis in G6PD-deficient patients).
• Artesunate IV reduced mortality by 35% vs. quinine in Asian trials and 22.5% in African children - this is a major viva/exam statistic.
• Do NOT use steroids in cerebral malaria - randomized trials showed higher mortality with glucocorticoids. This is a classic "do NOT do" viva question.
• Primaquine is contraindicated in pregnancy - G6PD status of fetus is unknown and risk of fetal hemolysis is unacceptable. Use chloroquine suppression weekly throughout pregnancy for P. vivax instead.
• G6PD testing is mandatory before primaquine or tafenoquine - these 8-aminoquinolines cause fatal hemolysis in G6PD-deficient patients.
• Chloroquine resistance in P. falciparum is mediated by mutation in PfCRT (chloroquine resistance transporter gene). This is the molecular mechanism.
• P. knowlesi has a 24-hour (quotidian) fever cycle - the fastest of all species.
• Malaria exerts evolutionary pressure: Sickle cell trait (HbAS), thalassemia, G6PD deficiency all provide partial protection → textbook example of balanced polymorphism.
• WHO severe malaria criteria to memorize: Cerebral malaria, severe anemia (Hb<7), ARDS, hyperparasitemia (>5%), hypoglycemia, AKI, DIC, shock, repeated seizures, hemoglobinuria.

High-Yield Viva Points

• Q: Why does malaria cause thrombocytopenia? A: Splenic sequestration of platelets + immune-mediated destruction (antibody-coated platelets).
• Q: Why can P. falciparum cause cerebral malaria but P. vivax cannot? A: Only P. falciparum expresses PfEMP1 (knobs) that bind ICAM-1/VCAM-1/CD36 on brain endothelium → RBC sequestration in cerebral microvasculature.
• Q: Why does the fever occur cyclically? A: Synchronized RBC rupture releases merozoites and pyrogens (TNF-α, IL-1, IL-6) every 48 or 72 hours.
• Q: Why is repeat smear needed? A: Parasitemia fluctuates; in early infection synchrony is incomplete; in P. falciparum, mature stages are sequestered. A single negative smear does NOT rule out malaria. Repeat 3 times over 24-48h.
• Q: What is the difference between relapse and recrudescence? A: Relapse = reactivation of dormant hypnozoites in liver (P. vivax/ovale only). Recrudescence = re-emergence from subtherapeutic blood-stage parasitemia (any species, including P. falciparum). P. falciparum does NOT relapse but can recrudesce.
• Q: Why is P. falciparum peripheral smear "ring-form only"? A: Schizonts and trophozoites are sequestered deep in microvasculature via PfEMP1 - they are not circulating in peripheral blood and therefore not seen on smear. A low-parasitemia smear in falciparum does NOT mean mild disease.

12. COMMON DIAGNOSTIC MISTAKES

🦠 TYPHOID FEVER (ENTERIC FEVER) - Complete Exam-Oriented Clinical Guide

1. DEFINITION

2. CAUSES (ETIOLOGY)

Causative Organisms

Exam pearl: "Enteric fever" is the collective term for typhoid + paratyphoid. They are clinically indistinguishable. S. Typhi alone causes true typhoid fever. Vaccination protects only against S. Typhi - NOT Paratyphi, hence paratyphoid is more common in vaccinated travelers.

Transmission

• Primary route: Fecal-oral (contaminated food and water)
• Infective dose: 10⁵-10⁶ bacteria (intermediate - lower than most Salmonellae due to Vi capsule)
• Reservoir: Humans ONLY (no animal reservoir - strictly human disease)
• Chronic carrier: The most important source; bacteria persist in the gallbladder (especially with gallstones); 1-5% of patients become chronic carriers for >1 year
• "Typhoid Mary": Classic example of a healthy chronic carrier (Mary Mallon) who was a cook and infected >50 people

Important Risk Factors

3. TYPES / CLASSIFICATION

By Causative Organism

• The "classic" and most severe form
• Responsible for 80% of enteric fever in endemic areas
• Full-blown syndrome with all classic features
• Risk of intestinal perforation and hemorrhage

• Clinically identical but generally milder and shorter course
• Lower mortality
• Increasingly common in travelers (not covered by most vaccines)
• Paratyphi A is the most common of the three

By Disease Course (Clinical Staging - Weeks)

By Carrier State

4. PATHOPHYSIOLOGY

Natural History Diagram (from Sherris & Ryan's Medical Microbiology)

Step-by-Step Pathophysiology Flowchart

Ingestion of S. Typhi in contaminated food/water
           ↓
GASTRIC ACID BARRIER - Survived by:
→ pH homeostasis system + acid shock proteins expressed by S. Typhi
→ Vi capsular polysaccharide provides additional protection
           ↓
Reaches SMALL INTESTINE (terminal ileum - Peyer's patches)
           ↓
S. Typhi invades M CELLS (specialized epithelial cells overlying Peyer's patches)
           ↓
Engulfed by submucosal MACROPHAGES
→ Vi polysaccharide BLOCKS neutrophil phagocytosis (by interfering with complement deposition)
→ This FAVORS macrophage uptake over neutrophil killing
→ S. Typhi survives inside macrophage: INHIBITS oxidative burst (respiratory burst)
→ Continues to multiply inside membrane-bound vacuole within macrophages
           ↓
Bacteria (inside macrophages) travel via LYMPHATICS to:
→ Mesenteric lymph nodes → THORACIC DUCT → bloodstream → 
→ LIVER, SPLEEN, BONE MARROW (all = reticuloendothelial system / RES)
           ↓
INCUBATION PERIOD (1-2 weeks): Silent multiplication in RES
→ No clinical symptoms yet
→ Mononuclear (not neutrophilic) inflammatory response in gut → minimal/no diarrhea early
→ Vi antigen downregulates innate Toll-like receptor responses in intestinal mucosa
           ↓
Burgeoning bacteria reach CRITICAL MASS in RES → flood into BLOODSTREAM
→ PRIMARY BACTEREMIA (Week 1)
→ LPS ENDOTOXIN enters blood → triggers fever (step-ladder pattern) and malaise
→ Fever rises SLOWLY over 72 hours → continuous high fever in Week 2
           ↓
Sustained bacteremia seeds other organs:
→ BILIARY TREE infected → bacteria re-enter intestine via bile → reinfects gut
→ PEYER'S PATCHES: hyperplasia → necrosis → ulceration (Week 3)
→ TERMINAL ILEUM / PROXIMAL COLON: ulcer perforates → intestinal perforation
   or erosion of blood vessels → hemorrhage
→ Other sites: urinary tract, bone, joints, meninges, heart (myocarditis)
           ↓
ENDOTOXIN + CYTOKINE EFFECTS:
→ Continuous fever (TNF-α, IL-1, IL-6)
→ Relative bradycardia (direct myocardial depression / vagal stimulation)
→ Hepatic involvement → mild jaundice, elevated LFTs
→ Bone marrow depression → leukopenia, thrombocytopenia, anemia
→ Encephalopathy (severe cases)
           ↓
WITHOUT TREATMENT: Natural resolution in Week 4 (in 90% of survivors)
→ Immunity: both TH1 and TH2 mediated
→ 1-5% → CHRONIC CARRIER STATE (gallbladder reservoir)

Why the Gut Pathology Matters

Week 1: Peyer's patches HYPERPLASIA (lymphoid swelling) → no ulcer yet
           ↓
Week 2: Peyer's patches NECROSIS → central sloughing
           ↓
Week 3: ULCERATION of Peyer's patches in terminal ileum
→ Ulcers are TRANSVERSE (perpendicular to long axis of bowel)
→ Penetration = INTESTINAL PERFORATION (5% of untreated cases)
→ Erosion of vessels = INTESTINAL HEMORRHAGE (10% of untreated)

Exam pearl: Typhoid ulcers are TRANSVERSE (across the bowel wall, following Peyer's patch distribution). Compare with TB ulcers which are also transverse but have undermined edges; contrast with typhoid where edges are clean. Carcinoma ulcers are irregular; amoebic ulcers are flask-shaped.

5. CLINICAL FEATURES

The Week-by-Week Clinical Progression

WEEK 1 - "FLU-LIKE" (Bacteremic onset)
• Fever: begins low-grade, rises in STEP-LADDER pattern each day
• Frontal headache (prominent, often the first complaint)
• Myalgia and arthralgia
• Malaise, lethargy, anorexia
• DRY COUGH (in ~30% - misleads to respiratory diagnosis)
• Constipation (more common than diarrhea in early typhoid)
• Blood culture: MOST POSITIVE this week (>90% positive)
• Patient looks unwell but not critically ill yet

WEEK 2 - "CLASSIC TYPHOID" (Sustained fever)
• Fever: continuous, 39-40°C, peaking in the afternoon
• RELATIVE BRADYCARDIA - pulse slower than expected for the fever
• ROSE SPOTS - faint salmon-pink maculopapular lesions appear
• Hepatomegaly and SPLENOMEGALY develop
• Abdominal pain, distension, tenderness (lower quadrants)
• Diarrhea may develop (often "pea-soup" stools - mild, watery)
• "Typhoid tongue" - white coated with red tip and edges
• Toxemia increases; patient appears "toxic"
• Blood culture: still positive, begins declining

WEEK 3 - "DANGER ZONE" (Complications)
• Fever persists at plateau
• INTESTINAL COMPLICATIONS:
  - Perforation: sudden severe abdominal pain, guarding, rigidity
  - Hemorrhage: blood per rectum, sudden fall in temperature and BP
• Encephalopathy: confusion, delirium, stupor ("typhoid state" / "muttering delirium")
• DIC: petechiae, oozing
• Myocarditis: tachycardia, ECG changes
• Stool + urine culture: most positive now

WEEK 4 - RESOLUTION or RELAPSE
• Gradual defervescence (temperature falls by lysis, not crisis)
• Relapse in 3-20% (milder than original illness)
• Convalescence takes weeks to months

Symptoms

Signs

Why Important Signs Occur

6. KEY SYMPTOMS THAT SUGGEST THE DIAGNOSIS

Hallmark Symptom

Step-ladder fever for 1 week + relative bradycardia (pulse-temperature dissociation) in a patient with travel to or residence in a typhoid-endemic area (South Asia, Southeast Asia, Africa, Latin America).

Classic Clinical Clues

Red Flag Findings (Complicated/Severe Typhoid)

• 🚨 Intestinal perforation: Sudden severe abdominal pain, guarding, rigidity, paradoxical fall in fever (temperature drops when perforation occurs - a diagnostic trap)
• 🚨 Intestinal hemorrhage: Fresh blood per rectum, sudden hypotension, fall in temperature
• 🚨 Encephalopathy: Confusion, delirium, stupor, coma ("typhoid state")
• 🚨 Myocarditis: New arrhythmia, cardiac failure signs in typhoid patient
• 🚨 DIC: Bleeding from multiple sites, petechiae, ecchymosis
• 🚨 Prolonged fever >3 weeks without diagnosis in a returning traveler = must rule out typhoid with bone marrow culture
• 🚨 Typhoid in pregnancy: High risk of abortion, preterm labor, maternal death

Exam memory hook - "The TYPHOID mnemonic" for classic features:

• T - Temperature: step-ladder rise
• Y - (wh)Y is the pulse slow? Relative bradycardia
• P - Peyer's patches → ulceration → perforation in Week 3
• H - Hepatosplenomegaly
• O - Onset: constipation before diarrhea
• I - Invasion: RES (liver, spleen, bone marrow, lymph nodes)
• D - Diagnostic clue: Rose spots + leukopenia

7. LABORATORY INVESTIGATIONS OF TYPHOID FEVER

COMPLETE BLOOD COUNT (CBC)

Exam tip: The classic triad on CBC = Leukopenia + Anemia + Thrombocytopenia in a febrile patient returning from South Asia = typhoid fever until proven otherwise. Leukocytosis suggests intestinal perforation (secondary peritonitis) as a complication.

BIOCHEMISTRY

DISEASE-SPECIFIC / MICROBIOLOGICAL TESTS

Culture Yield by Week and Site - Summary Table

Exam pearl: Blood culture = best in Week 1; Stool culture = best in Week 3; Bone marrow culture = best at ANY week (even after antibiotics).

IMAGING FINDINGS

8. DIFFERENTIAL DIAGNOSIS

Key rule: In any febrile patient returning from South Asia (especially India, Pakistan, Bangladesh, Nepal), typhoid must be the first differential considered. Blood cultures must be drawn before starting antibiotics - this single step is the most common preventable diagnostic error.

9. SHORT CLINICAL CASES

Case 1 - Classic Typhoid Fever

• Travel to Pakistan (highest-risk country for typhoid) + no vaccination mentioned
• Step-ladder fever rising incrementally over 5 days - the pattern most characteristic of typhoid
• Relative bradycardia (pulse 74 with fever 39.6°C - expected pulse would be ~110-120 bpm) is pathognomonic for typhoid/brucellosis/leptospirosis
• Constipation rather than diarrhea in Week 1 - classic feature (counterintuitive but examinable)
• Dry cough misleads toward respiratory diagnosis - but typhoid's early cough is from endotoxemia, not pulmonary infection
• Leukopenia + thrombocytopenia in a febrile patient = typhoid fever profile (bacterial infections cause leukocytosis)
• Next step: Blood cultures (3 sets) before any antibiotics; start empiric ceftriaxone or azithromycin while awaiting sensitivity

Case 2 - Complicated Typhoid (Intestinal Perforation)

• 3 weeks of untreated fever - classic time frame for intestinal perforation (Week 3 = danger zone)
• Paradoxical sudden fall in temperature at time of perforation - a diagnostic trap; the peritoneal cavity acts as a heat sink; simultaneously pulse shoots up (surgical peritonitis)
• Board-like rigidity + absent bowel sounds = peritonitis from perforation
• Pneumoperitoneum (free air under diaphragm on erect CXR/AXR) = confirms hollow viscus perforation
• Hemodynamic instability = septic shock from fecal peritonitis
• Perforation site: antimesenteric border of terminal ileum at a necrotic Peyer's patch (single perforation, transverse)
• Mortality of typhoid perforation: 10-32% even with surgery
• Next step: Emergency laparotomy (primary closure or resection + anastomosis depending on findings); IV ceftriaxone + metronidazole (cover gut flora); ICU monitoring; blood cultures before antibiotics if time permits

Exam trap: The sudden fall in temperature with worsening clinical condition in a Week 3 typhoid patient is NOT an improvement - it signals perforation. Never be falsely reassured by a falling temperature in this context.

10. TREATMENT OF TYPHOID FEVER

A. NON-PHARMACOLOGICAL TREATMENT

Important note: The use of corticosteroids is only for severe typhoid with encephalopathy or shock - this is the OPPOSITE of cerebral malaria where steroids are harmful. This distinction is a classic exam question.

B. PHARMACOLOGICAL TREATMENT

DRUG RESISTANCE BACKGROUND (Critical for Exam)

Exam alarm: XDR S. Typhi leaves azithromycin as the only remaining oral option. For XDR, IV meropenem or carbapenems become necessary. Typhoid Conjugate Vaccine (TCV) is now urgently recommended to prevent XDR spread.

PHARMACOLOGICAL DRUG TABLE

• 🥇 DOC / First-line
• 🥈 Alternative / Second-line
• 🚨 Severe / Emergency
• ⛔ Now UNRELIABLE due to resistance

Treatment Summary by Clinical Scenario

Vaccination (Prevention Pharmacology)

11. CLINICAL PEARLS

Bedside Clues

• The combination of step-ladder fever + relative bradycardia + constipation + leukopenia in a patient from South Asia is typhoid until blood cultures say otherwise. You do not need all four - even two or three in the right epidemiological context should prompt blood cultures immediately.
• Feel the pulse while reading the temperature. In typhoid, the pulse feels inappropriately slow for the fever. Normal rule: every 1°C rise above 37°C should raise the pulse by ~10 bpm. If the pulse fails to rise, think typhoid, brucellosis, or leptospirosis.
• Rose spots are transient and subtle. They last only 3-4 days, appear on the abdomen/lower chest, and blanch on pressure. They are easily missed on dark skin. If you are examining a febrile tropical traveler, actively look for rose spots under good lighting - they confirm typhoid clinically even before cultures return.
• Week 3 is the danger zone. Any typhoid patient who suddenly appears BETTER (fever drops, becomes afebrile) while simultaneously deteriorating hemodynamically (rising pulse, falling BP, rigid abdomen) has perforated. This paradox - temperature falling while condition worsens - is the most dangerous moment in typhoid management.
• Leukocytosis in a known typhoid patient = complication. A rising WBC in a patient being treated for typhoid = developing intestinal perforation with peritonitis or secondary bacterial infection. It is NOT a sign of treatment response.

High-Yield Exam Facts

• S. Typhi is a strictly human pathogen - there is NO animal reservoir. All cases trace back to a human source (carrier or active case). This distinguishes it from Salmonella enteritidis/typhimurium (zoonotic, from poultry/eggs/reptiles).
• Blood culture is most positive in Week 1 (80-90%); Bone marrow culture is the gold standard at ANY time (90% even after antibiotics).
• Widal test: A single titre means little. Only a 4-fold rise in convalescent titre compared to acute sample is meaningful. The CDC does NOT recommend Widal for acute diagnosis due to poor specificity. It generates numerous false positives in endemic populations due to prior infection/vaccination.
• Bone marrow culture remains 90% positive even after 5-7 days of antibiotics - because bacteria are hidden inside macrophages protected from antibiotic penetration.
• Dexamethasone is indicated in typhoid ONLY for severe encephalopathy or shock (reduces mortality from ~56% to ~10%). Contrast: Dexamethasone is CONTRAINDICATED in cerebral malaria. This is a high-frequency viva question.
• Relapse rate: 3-20% even after adequate antibiotic treatment, typically 2 weeks after defervescence. Relapse is milder than original illness.
• Without treatment: mortality 10-20%. With appropriate antibiotics: mortality <1%.
• Typhoid Mary: Mary Mallon - the classic chronic asymptomatic carrier who worked as a cook and caused multiple typhoid outbreaks. Demonstrates: gallbladder is the chronic carrier reservoir; bacteria shed intermittently in stool.
• MDR typhoid (resistant to chloramphenicol + ampicillin + TMP-SMX) has been circulating since the 1980s - plasmid-encoded. XDR typhoid emerged in Pakistan in 2016 - additionally resistant to fluoroquinolones and third-generation cephalosporins; only azithromycin (and carbapenems) remain active.
• Ciprofloxacin is NO LONGER the empiric drug of choice for travelers from South Asia. Switch to azithromycin or ceftriaxone as empiric therapy.
• Typhoid intestinal perforation is always at the antimesenteric border of the terminal ileum (at the site of Peyer's patches). Ulcers are transverse (following the circumferential Peyer's patch distribution).

High-Yield Viva Points

• Q: Why is there relative bradycardia in typhoid? A: LPS endotoxin directly depresses SA node conduction, stimulates vagal tone, and inhibits sympathetic response - pulse fails to rise proportionally with temperature.
• Q: Why does typhoid cause leukopenia, not leukocytosis? A: S. Typhi infects and replicates inside macrophages in the bone marrow → direct suppression of myeloid precursors + cytokine (IL-10, TGF-β) downregulation of granulopoiesis.
• Q: Why does constipation precede diarrhea in typhoid? A: In Week 1, Vi antigen inhibits Toll-like receptor signaling in intestinal mucosa → suppresses secretory/inflammatory response → constipation. In Week 2-3, biliary re-seeding and Peyer's patch ulceration overcome this → diarrhea supervenes.
• Q: Why is bone marrow culture positive even after antibiotics? A: S. Typhi survive inside macrophage vacuoles in bone marrow; antibiotics have poor intracellular penetration into the macrophage phagosome. Bacteria are shielded from antibiotic activity.
• Q: Name the two typhoid vaccines and their protection against Paratyphi. A: Ty21a (oral, live attenuated) offers some protection against Paratyphi A and B. Vi polysaccharide vaccine offers NO protection against Paratyphi (which lacks the Vi antigen). TCV (typhoid conjugate vaccine) is Vi-based → no Paratyphi protection.
• Q: What is the Weil-Felix reaction? A: An agglutination test using Proteus antigens to detect rickettsial antibodies - NOT typhoid. Confusingly named like Widal; do not mix them up.

12. COMMON DIAGNOSTIC MISTAKES

🦟 DENGUE FEVER - Complete Exam-Oriented Clinical Guide

1. DEFINITION

2. CAUSES (ETIOLOGY)

The Virus

Vectors

Exam pearl: Aedes mosquitoes bite during the DAY (not night like Anopheles). The standard bed nets used for malaria prevention do NOT protect against dengue. This is a high-yield distinction.

Important Risk Factors

3. TYPES / CLASSIFICATION

WHO 2009 Classification (Current - Most Used)

Type 1: Undifferentiated Fever (Viral Syndrome)

• Mildest form; especially in young children
• Non-specific febrile illness with no clear clinical diagnosis
• Only identifiable retrospectively by serology
• No hemorrhage, no plasma leakage

Type 2: Dengue Fever (DF)

• The "classic" dengue - self-limiting, rarely fatal
• High fever, severe myalgia, arthralgia ("breakbone fever"), retro-orbital pain, headache
• Rash (biphasic): flushing early, then maculopapular rash on trunk spreading outward
• May have unusual hemorrhage (petechiae) or positive tourniquet test
• No significant plasma leakage
• Sub-types: DF without hemorrhage; DF with unusual hemorrhage

Type 3: Dengue Hemorrhagic Fever (DHF)

• Severe form with plasma leakage - the life-threatening form
• All four WHO criteria must be met for diagnosis:
  1. Fever lasting 2-7 days
  2. Hemorrhagic manifestations (positive tourniquet test, petechiae, ecchymoses, mucosal bleeding)
  3. Thrombocytopenia: platelets ≤ 100,000/mm³
  4. Objective plasma leakage: hematocrit rise ≥20%, pleural effusion, ascites, hypoalbuminemia
• Graded I-IV by severity
• Typically occurs in second infections with a different serotype

Grades I-II = DHF without shock; Grades III-IV = Dengue Shock Syndrome (DSS)

Type 4: Expanded Dengue Syndrome / Isolated Organopathy

• Unusual manifestations: dengue encephalitis, dengue myocarditis, dengue hepatitis (severe), dengue nephropathy, dengue retinopathy
• Occurs without obvious plasma leakage or shock
• Increasingly recognized; not rare

4. PATHOPHYSIOLOGY

Course of Dengue Illness (from Park's Textbook)

Step-by-Step Pathophysiology Flowchart

Infected Aedes aegypti mosquito bites human
           ↓
DENGUE VIRUS (DENV 1-4) injected into skin
→ Virus infects skin dendritic cells (Langerhans cells) and macrophages
→ Travels via lymphatics to regional lymph nodes
→ PRIMARY VIREMIA: virus enters bloodstream
           ↓
VIRUS INFECTS MONOCYTES/MACROPHAGES (the main target cells)
→ Replicates within mononuclear phagocytes
→ Secondary viremia: widespread dissemination to liver, spleen, lymph nodes, bone marrow
→ INCUBATION PERIOD: 4-7 days (range 3-10 days; clinically silent)
           ↓
FEBRILE PHASE begins (Days 1-3):
→ Viral PAMPs trigger innate immunity → cytokine release: IFN-α, TNF-α, IL-1, IL-6
→ HIGH FEVER (39-40°C), sudden onset
→ Severe myalgia and arthralgia: cytokines cause muscle/joint inflammation
→ Headache: cytokines trigger prostaglandin-mediated neuroinflammation
→ Retro-orbital pain: congestion of periorbital vessels
→ Early rash: facial flushing from vasodilation
           ↓
[In MOST patients - simple dengue fever]:
Defervescence around Day 3-5
→ Immune clearance of virus
→ Recovery over 7-10 days
           ↓
[In SECOND INFECTION WITH A DIFFERENT SEROTYPE - Severe Dengue]:

ANTIBODY-DEPENDENT ENHANCEMENT (ADE):
→ Pre-existing non-neutralizing antibodies from previous infection bind new serotype
→ Virus-antibody complex binds Fc receptors on monocytes/macrophages
→ INCREASES viral entry and replication in MORE macrophages
→ Far greater viral load than primary infection
           ↓
MASSIVE CYTOKINE STORM:
→ Infected macrophages + CD4+ and CD8+ T cells secrete: IFN-γ, TNF-α, IL-2, IL-8
→ Complement activation via circulating immune complexes (C3a, C5a)
→ These mediators act on VASCULAR ENDOTHELIUM
           ↓
INCREASED VASCULAR PERMEABILITY (the central event in DHF):
→ Cytokines damage tight junctions between endothelial cells
→ Plasma (water + proteins) leaks OUT of blood vessels into:
   → Pleural cavity (pleural effusion - predominantly RIGHT-SIDED)
   → Peritoneal cavity (ascites)
   → Retroperitoneum
   → Interstitial tissues (edema)
→ HEMATOCRIT RISES (hemoconcentration from plasma loss)
→ Blood volume FALLS → SHOCK (Dengue Shock Syndrome)
           ↓
THROMBOCYTOPENIA (parallel mechanism):
→ Dengue virus directly infects megakaryocytes in bone marrow → suppressed platelet production
→ Activated complement + antibodies destroy circulating platelets (immune-mediated)
→ Platelets consumed at sites of endothelial damage
→ PLATELET COUNT FALLS rapidly in critical phase
→ Combined with capillary fragility: HEMORRHAGE
           ↓
CRITICAL PHASE (Days 3-7 - period of defervescence):
→ Temperature drops (looks like improvement - DANGEROUS TRAP)
→ Plasma leakage peaks over 24-48 hours
→ Shock can develop RAPIDLY during this "apparent improvement"
           ↓
RECOVERY PHASE (Days 7-10):
→ Capillary integrity restored
→ Leaked plasma RE-ABSORBED back into circulation
→ Hematocrit falls (dilutional effect of fluid reabsorption)
→ Platelet count recovers
→ RISK: Fluid overload/pulmonary edema if too much IV fluid was given during critical phase

Why Second Infections Are More Dangerous (ADE - Exam Cornerstone)

FIRST INFECTION (DENV-1) → IgG antibodies against DENV-1 formed
           ↓
SECOND INFECTION (DENV-2):
Pre-existing DENV-1 antibodies recognize DENV-2 partially but CANNOT NEUTRALIZE it
→ Instead, antibody-virus complex binds Fc receptors on monocytes
→ TROJAN HORSE effect: virus gets DIRECTLY DELIVERED into the cell
→ 100× more macrophages infected compared to primary infection
→ Cytokine storm 100× more intense → DHF/DSS

5. CLINICAL FEATURES

Three-Phase Clinical Course

PHASE 1: FEBRILE PHASE (Days 1-3)
↓ High fever (39-40°C), sudden onset
↓ Severe frontal headache
↓ Retro-orbital pain (especially on eye movement or eye pressure)
↓ Severe myalgia + arthralgia = "BREAKBONE FEVER" (pain so severe it feels like bones breaking)
↓ Facial flushing
↓ Nausea and vomiting
↓ Anorexia
↓ Early rash: diffuse facial flushing or mottling

PHASE 2: CRITICAL PHASE (Days 3-7)
↓ Fever begins to FALL (defervescence)
↓ "WARNING SIGNS" appear (see below)
↓ Plasma leakage → pleural effusion, ascites, periorbital edema
↓ Hematocrit RISES ≥20%
↓ Platelets FALL rapidly
↓ Hemorrhagic manifestations appear
↓ If severe: SHOCK, organ impairment

PHASE 3: RECOVERY PHASE (Days 7-10)
↓ General well-being returns
↓ Appetite returns
↓ Second rash: "Isles of white in a sea of red" - characteristic convalescent rash
↓ Diuresis (reabsorption of leaked plasma)
↓ Bradycardia common
↓ Platelet count recovers (later than WBC)
↓ RISK: Fluid overload if excessive IV fluids were given during critical phase

Symptoms

Signs

Why Important Signs Occur

6. KEY SYMPTOMS THAT SUGGEST THE DIAGNOSIS

Hallmark Symptom

Sudden high fever + severe "breakbone" myalgia + retro-orbital pain + thrombocytopenia in a patient from or returning from a tropical/subtropical area - especially if accompanied by a biphasic rash or positive tourniquet test.

Classic Clinical Clues

Warning Signs (RED FLAG - Critical Phase Is Beginning)

• 🚨 Abdominal pain or tenderness (persistent, worsening)
• 🚨 Persistent vomiting (≥3 vomits in 24 hours)
• 🚨 Clinical fluid accumulation (pleural effusion, ascites, facial/leg edema)
• 🚨 Mucosal bleeding (gum bleeding, epistaxis, hematemesis, melena)
• 🚨 Lethargy or restlessness (altered mental status)
• 🚨 Liver enlargement >2 cm below costal margin
• 🚨 Rapid rise in hematocrit with rapid drop in platelet count

The most dangerous clinical trap in dengue: When fever falls (defervescence around Day 3-5), it looks like the patient is getting better. This is actually the START of the critical phase when plasma leakage peaks. Patients (and sometimes doctors) go home or relax monitoring at precisely the moment closest monitoring is needed. Any patient who "improves" from dengue fever but then develops abdominal pain, persistent vomiting, or hypotension has entered Dengue Shock Syndrome.

Red Flag Findings - Severe Dengue Criteria (WHO 2009)

• 🚨 Severe plasma leakage → dengue shock (pulse pressure ≤20 mmHg; narrow pulse + rapid heart rate = DSS)
• 🚨 Severe bleeding → hematemesis, melena, massive hematuria, vaginal bleeding
• 🚨 Severe organ impairment: - Liver: AST/ALT ≥1000 IU/L (severe hepatitis) - CNS: altered consciousness, seizures (dengue encephalitis) - Heart: tachycardia out of proportion, poor cardiac function (dengue myocarditis) - Kidneys: oliguria, rising creatinine (dengue nephropathy)

Exam memory hook - "DENGUE" warning signs mnemonic:

• D - Drop in platelets with rise in hematocrit
• E - Extreme/persistent vomiting
• N - No urine (oliguria)
• G - Gut pain (abdominal tenderness)
• U - Unease (restlessness/lethargy)
• E - Edema/fluid accumulation (pleural effusion, ascites)

🦟 DENGUE FEVER - Complete Exam-Oriented Clinical Guide

1. DEFINITION

2. CAUSES (ETIOLOGY)

The Virus

Vectors

Exam pearl: Aedes mosquitoes bite during the DAY - not at night like Anopheles (malaria). Standard bed nets do NOT protect against dengue.

Important Risk Factors

3. TYPES / CLASSIFICATION

WHO 2009 Classification (Current Standard)

Type 1: Undifferentiated Fever (Viral Syndrome)

• Mildest form, especially in young children
• Non-specific febrile illness with no clear clinical diagnosis
• Only identifiable retrospectively by serology
• No hemorrhage, no plasma leakage

Type 2: Dengue Fever (DF)

• Classic dengue - self-limiting, rarely fatal
• Sudden high fever, severe myalgia/arthralgia ("breakbone fever"), retro-orbital pain, headache, rash
• May have unusual hemorrhage (petechiae) or positive tourniquet test
• No significant plasma leakage
• Sub-types: DF without hemorrhage; DF with unusual hemorrhage

Type 3: Dengue Hemorrhagic Fever (DHF)

• Severe form with plasma leakage - the life-threatening presentation
• All four WHO criteria must be met:
  1. Fever lasting 2-7 days
  2. Hemorrhagic manifestations (positive tourniquet test, petechiae, ecchymoses, mucosal bleeding)
  3. Thrombocytopenia: platelets ≤100,000/mm³
  4. Objective plasma leakage: hematocrit rise ≥20%, pleural effusion, ascites, or hypoalbuminemia

Grades I-II = DHF without shock; Grades III-IV = Dengue Shock Syndrome (DSS)

Type 4: Expanded Dengue Syndrome / Isolated Organopathy

• Unusual manifestations without classic plasma leakage
• Includes: dengue encephalitis, dengue myocarditis, dengue hepatitis (severe), dengue nephropathy, dengue retinopathy
• Increasingly recognized; requires high clinical suspicion

4. PATHOPHYSIOLOGY

Course of Dengue Illness

Step-by-Step Pathophysiology Flowchart

Infected Aedes aegypti mosquito bites human
           ↓
DENGUE VIRUS injected into skin
→ Infects dendritic cells (Langerhans cells) and skin macrophages
→ Travels via lymphatics to regional lymph nodes
→ PRIMARY VIREMIA: virus enters bloodstream
           ↓
VIRUS INFECTS MONOCYTES/MACROPHAGES (the main target cells)
→ Replicates within mononuclear phagocytes
→ Secondary viremia: disseminates to liver, spleen, lymph nodes, bone marrow
→ INCUBATION PERIOD: 4-7 days (range 3-10 days; clinically silent)
           ↓
FEBRILE PHASE (Days 1-3):
→ Viral PAMPs trigger innate immunity → cytokine release: IFN-α, TNF-α, IL-1, IL-6
→ SUDDEN HIGH FEVER (39-40°C)
→ Severe myalgia/arthralgia: cytokines inflame muscle and joints
→ Headache: prostaglandin-mediated neuroinflammation
→ Retro-orbital pain: periorbital vascular congestion
→ Early rash: cytokine-driven vasodilation → facial flushing
           ↓
[In MOST patients → simple dengue fever]:
Defervescence around Day 3-5 → immune clearance → full recovery in 7-10 days
           ↓
[In SECOND INFECTION WITH A DIFFERENT SEROTYPE → Severe Dengue]:

ANTIBODY-DEPENDENT ENHANCEMENT (ADE) - THE KEY MECHANISM:
→ Pre-existing non-neutralizing IgG from previous infection binds new serotype
→ Cannot neutralize virus but virus-antibody complex binds Fc receptors on macrophages
→ TROJAN HORSE: virus delivered DIRECTLY into far more macrophages
→ Viral load 100× higher than primary infection
→ MASSIVE CYTOKINE STORM: IFN-γ, TNF-α, IL-2, IL-8 from infected macrophages
   + activated CD4+ and CD8+ T cells
→ Complement activation via circulating immune complexes (C3a, C5a)
           ↓
INCREASED VASCULAR PERMEABILITY (the central event in severe dengue):
→ Cytokines disrupt endothelial tight junctions
→ Plasma (water + proteins) leaks OUT of blood vessels into:
   → Pleural cavity (pleural effusion - predominantly RIGHT-SIDED)
   → Peritoneal cavity (ascites)
   → Interstitial tissues (edema)
→ HEMATOCRIT RISES ≥20% (hemoconcentration from plasma loss)
→ Intravascular volume FALLS → SHOCK (Dengue Shock Syndrome)
           ↓
THROMBOCYTOPENIA (parallel mechanism):
→ Virus directly infects bone marrow megakaryocytes → suppressed production
→ Antibody + complement-mediated destruction of circulating platelets
→ Platelet consumption at damaged endothelial sites
→ + Capillary fragility → HEMORRHAGE
           ↓
CRITICAL PHASE (Days 3-7 - period of defervescence):
→ Temperature DROPS (appears like improvement - THE MOST DANGEROUS TRAP)
→ Plasma leakage PEAKS over 24-48 hours
→ Shock develops RAPIDLY during apparent improvement
           ↓
RECOVERY PHASE (Days 7-10):
→ Capillary integrity restored
→ Leaked plasma RE-ABSORBED back into circulation
→ Hematocrit falls; platelets recover
→ RISK: Fluid overload/pulmonary edema if too much IV fluid given during critical phase

The ADE Mechanism (The Exam Cornerstone)

1st Infection (DENV-1) → IgG antibodies against DENV-1 formed → recovery
           ↓
2nd Infection (DENV-2):
Pre-existing DENV-1 antibodies recognize DENV-2 but CANNOT neutralize it
→ Antibody-virus complex binds Fc receptors on monocytes/macrophages
→ TROJAN HORSE: virus gets directly delivered into cells
→ Far more macrophages infected → cytokine storm → DHF/DSS

5. CLINICAL FEATURES

Three-Phase Clinical Course

FEBRILE PHASE (Days 1-3):
→ Sudden high fever 39-40°C
→ Severe frontal headache
→ RETRO-ORBITAL PAIN (pain behind eyes on movement/pressure)
→ BREAKBONE MYALGIA + arthralgia
→ Facial flushing
→ Nausea, vomiting, anorexia
→ Early rash: diffuse facial flushing/mottling

CRITICAL PHASE (Days 3-7):
→ Fever FALLS (defervescence - looks like improvement)
→ WARNING SIGNS appear (see below)
→ Plasma leakage → pleural effusion (right > left), ascites
→ Hematocrit RISES ≥20%
→ Platelet count FALLS rapidly (may reach <20,000)
→ Hemorrhagic manifestations: petechiae, gum bleeding, hematemesis
→ If severe: DENGUE SHOCK SYNDROME

RECOVERY PHASE (Days 7-10):
→ General well-being returns
→ Appetite returns
→ Second rash: "Isles of white in a sea of red" (convalescent rash)
→ Diuresis (plasma reabsorption)
→ Bradycardia (characteristic finding in recovery)
→ RISK: Fluid overload from reabsorbed plasma + IV fluids given

Symptoms

Signs

Why Important Signs Occur

6. KEY SYMPTOMS THAT SUGGEST THE DIAGNOSIS

Hallmark Symptom

Sudden high fever + severe "breakbone" myalgia + retro-orbital pain + thrombocytopenia in a patient from or returning from a tropical area - especially with a biphasic rash and positive tourniquet test.

Classic Clinical Clues

Warning Signs - RED FLAGS (Critical Phase Onset)

• 🚨 Abdominal pain or tenderness (persistent, worsening)
• 🚨 Persistent vomiting (≥3 episodes in 24 hours)
• 🚨 Clinical fluid accumulation (pleural effusion, ascites, periorbital/limb edema)
• 🚨 Mucosal bleeding (gum, epistaxis, hematemesis, melena, menorrhagia)
• 🚨 Lethargy or restlessness (reduced brain perfusion)
• 🚨 Liver enlargement >2 cm below costal margin
• 🚨 Rapid rise in hematocrit with rapid fall in platelet count

Red Flags for Severe Dengue

• 🚨 Severe plasma leakage → DSS: narrow pulse pressure ≤20 mmHg (e.g., 100/80 mmHg); cold extremities; capillary refill >2 seconds
• 🚨 Severe bleeding: hematemesis, melena, massive hemorrhage
• 🚨 Severe organ impairment: AST/ALT ≥1000 (hepatitis); altered consciousness (encephalitis); severe cardiac dysfunction (myocarditis); oliguria (nephropathy)

The most dangerous clinical trap in dengue: When fever falls around Day 3-5, it looks like the patient is improving. This is actually the START of the critical phase when plasma leakage is at its worst. Patients (and clinicians) relax at the exact moment maximum vigilance is needed. Never discharge a dengue patient just because the fever has broken.

Exam memory hook - "DENGUE" warning signs:

• D - Drop in platelets / rise in hematocrit
• E - Excessive vomiting (persistent)
• N - No urine (oliguria)
• G - Gut pain (persistent abdominal tenderness)
• U - Unease (restlessness or lethargy)
• E - Edema/fluid accumulation (pleural effusion, ascites)

7. LABORATORY INVESTIGATIONS OF DENGUE FEVER

COMPLETE BLOOD COUNT (CBC)

Exam-critical rule: Monitor hematocrit every 4-6 hours in dengue with warning signs. A rapidly decreasing platelet count in parallel with a rising hematocrit = transition to critical phase. This combination is the most clinically important CBC pattern in dengue.

BIOCHEMISTRY

DISEASE-SPECIFIC TESTS

Timing of Diagnostic Tests - Critical Summary

IMAGING FINDINGS

8. DIFFERENTIAL DIAGNOSIS

Clinical exam principle: Among all differentials, Chikungunya is the hardest to distinguish from dengue because it uses the SAME vector. The key distinction: arthralgia in chikungunya vs. myalgia in dengue; chikungunya arthritis can persist for months while dengue arthralgia is brief.

9. SHORT CLINICAL CASES

Case 1 - Classic Dengue Fever with Warning Signs

• Travel to Thailand (highly endemic for all 4 DENV serotypes) + sudden explosive onset = classic dengue epidemiology and presentation
• Retro-orbital pain (pain behind eyes on movement) - near-pathognomonic for dengue; always ask for it
• Breakbone myalgia so severe he cannot walk - characteristic of dengue's cytokine-driven myalgia
• NS1 antigen positive on Day 3 - confirms dengue during the febrile/viremic phase (Days 1-5)
• Leukopenia (2,800) + thrombocytopenia (68,000) = classic dengue CBC pattern
• The most dangerous moment: fever partially breaks (appears like improvement) but hematocrit has risen from 38% to 47% = a 23.7% rise = plasma leakage beginning - this is crossing from febrile to critical phase
• Warning signs are now all present: persistent vomiting + abdominal pain + dizziness (orthostatic hypotension) = imminent DHF/shock
• Next step: Immediate hospitalization; IV isotonic fluid resuscitation; hematocrit monitoring every 4-6 hours; platelet monitoring; avoid NSAIDs/aspirin; do NOT discharge despite apparent "improvement" of fever

Case 2 - Dengue Shock Syndrome (Severe Dengue)

• Age 9, endemic area (Chennai) = classic demographic for severe dengue
• Day 5 - the fever has just broken = this IS the critical phase (Days 3-7 of defervescence)
• Pulse pressure of only 10 mmHg (88/78) = the classic early shock sign of DSS (WHO criterion: pulse pressure ≤20 mmHg). The diastolic rises as peripheral vasoconstriction compensates while systolic falls - the narrowing pulse pressure indicates falling cardiac output and hypovolemia
• Cold extremities + weak thready pulse + capillary refill 4 sec + sleepiness (reduced brain perfusion) = compensated shock rapidly becoming decompensated
• Hematocrit 56% vs. baseline 37% = a 51% rise - massive plasma leakage from vascular space
• Right-sided pleural effusion (dullness at right base) + ascites = plasma in third spaces confirms DHF criteria
• Petechiae + platelets 22,000 = hemorrhagic manifestations
• All 4 DHF criteria met + signs of shock = DHF Grade III (Dengue Shock Syndrome)
• Next step: IMMEDIATE IV isotonic crystalloid bolus (10-20 mL/kg over 15-30 minutes); repeat and reassess; switch to colloid if no improvement; continuous monitoring of vital signs, urine output, and hematocrit; avoid over-hydration (risk of pulmonary edema in recovery phase). Mortality without treatment: >10%; with prompt fluid resuscitation: <1%

Exam trap illustrated by Case 2: The child's fever broke yesterday - at this point many caregivers and even some physicians think the worst is over and the child is recovering. In dengue, this is the most dangerous assumption. The falling temperature signals the START of plasma leakage, not resolution. Any child (or adult) becoming quiet, lethargic, or complaining of abdominal pain after dengue fever breaks must be assessed urgently for DSS.

10. TREATMENT OF DENGUE FEVER

A. NON-PHARMACOLOGICAL TREATMENT

B. PHARMACOLOGICAL TREATMENT

Core principle for dengue pharmacology: There is NO antiviral drug for dengue. Treatment is entirely supportive. Dengue pharmacotherapy consists of what you SHOULD use (paracetamol, IV fluids, colloids) and - critically - what you must NEVER use (NSAIDs, aspirin, corticosteroids, prophylactic platelet transfusions, antibiotics unless secondary bacterial infection is proven).

PRIORITY LEGEND

• 🥇 DOC / Essential first-line
• 🚨 Emergency/critical phase drug
• ⛔ CONTRAINDICATED - do NOT use

Treatment Decision Flowchart by Severity

ALL DENGUE PATIENTS
→ Stop all NSAIDs/aspirin immediately
→ Start paracetamol only for fever/pain
→ Assess for warning signs
           ↓
NO WARNING SIGNS (Simple DF):
→ Oral hydration 2-3 L/day (ORS/fruit juice/coconut water)
→ Paracetamol for fever
→ Daily CBC + hematocrit monitoring
→ Return IMMEDIATELY if warning signs develop
→ Discharge when afebrile ≥24h, no warning signs, stable HCT
           ↓
WARNING SIGNS PRESENT (Dengue with warning signs):
→ ADMIT to hospital
→ IV isotonic crystalloid (RL or NS): 5-7 mL/kg/hour
→ Reassess every 1-2 hours; adjust fluid rate by HCT and clinical response
→ Urine output monitoring (target 0.5 mL/kg/hour)
→ Serial HCT every 4-6 hours
           ↓
SEVERE DENGUE / DSS (DHF Grade III-IV):
→ ICU/high-dependency care
→ IV crystalloid BOLUS: 10-20 mL/kg over 15-30 min
→ Reassess after each bolus: BP, pulse pressure, capillary refill, HCT
→ If no improvement after ~1000 mL crystalloid → SWITCH TO COLLOID
→ Oxygen for all shock patients
→ Blood transfusion if overt hemorrhage/refractory shock + falling HCT
→ FFP if DIC with active bleeding
→ Platelet transfusion ONLY for active hemorrhage + platelets <20,000
           ↓
RECOVERY PHASE (Day 7-10):
→ REDUCE IV FLUIDS immediately when HCT falls (plasma reabsorbing)
→ Monitor for fluid overload: rising BP, bradycardia, respiratory distress
→ Switch to oral fluids as soon as possible
→ Continue monitoring for pulmonary edema

Dengue Vaccines (Prevention Pharmacology)

11. CLINICAL PEARLS

Bedside Clues

• Always ask specifically about retro-orbital pain - pain behind the eyes on movement or pressure. Patients rarely volunteer it unless asked. It is near-pathognomonic for dengue and quickly separates dengue from influenza, typhoid, and most other febrile illnesses.
• Measure the pulse pressure at every examination in any dengue patient during defervescence. Pulse pressure = systolic BP minus diastolic BP. Normal is >40 mmHg. Pulse pressure narrowing to ≤20 mmHg (e.g., 100/80) = early DSS. The diastolic RISES before the systolic falls - this is the first hemodynamic sign of shock in dengue and is easily missed if you only measure systolic BP.
• Watch the hematocrit, not just the platelet count. Platelet count decline is expected and by itself does not indicate DSS. It is the COMBINATION of rising hematocrit + falling platelets that signals critical phase plasma leakage - the hematocrit is the more actionable number.
• The recovery phase is as dangerous as the critical phase. When plasma reabsorbs (Days 7-10), patients receiving IV fluids can develop acute pulmonary edema. A sudden rise in blood pressure, bounding pulse, or breathing difficulty in a recovering dengue patient = fluid overload. Reduce IV fluids immediately.
• Gallbladder wall edema on ultrasound = earliest sign of plasma leakage. It appears before clinical ascites or pleural effusion are detectable. In any febrile patient with dengue suspicion, an ultrasound abdomen showing gallbladder wall thickening >3 mm is an early alarm.

High-Yield Exam Facts

• Four serotypes (DENV 1-4). Infection with one confers lifelong immunity to THAT serotype only; second infection with a DIFFERENT serotype = highest risk of DHF/DSS via Antibody-Dependent Enhancement (ADE).
• Aedes aegypti bites during the DAY (not at night). Standard malaria bed nets do NOT protect against dengue.
• NS1 antigen positive: Days 1-5. Dengue IgM positive: Day 5 onwards. This is the most tested diagnostic sequence in exams.
• DHF four criteria (all four must be present): (1) Fever 2-7 days, (2) Hemorrhagic manifestations, (3) Platelets ≤100,000/mm³, (4) Evidence of plasma leakage (HCT rise ≥20%, pleural effusion, ascites, hypoalbuminemia).
• DSS diagnostic criteria: DHF + narrow pulse pressure ≤20 mmHg OR frank hypotension.
• Aspirin and NSAIDs are absolutely contraindicated - worsen bleeding in thrombocytopenic patients + cause Reye's syndrome in children.
• Corticosteroids do NOT help in dengue - multiple RCTs showed no benefit; this is opposite to cerebral malaria where dexamethasone is contraindicated, AND opposite to typhoid shock where dexamethasone helps.
• Prophylactic platelet transfusion is NOT recommended even with very low platelet counts (20,000-50,000) unless the patient has active significant hemorrhage. Platelets recover spontaneously once the infection resolves.
• CRP is typically LOW in dengue despite high fever - because dengue is a viral illness; bacterial infections raise CRP much higher. This is a useful bedside triage tool.
• Bradycardia during the recovery phase is a characteristic dengue finding - do not mistake it for cardiac pathology. It is a vagal response during convalescence and resolves spontaneously.
• "Isles of white in a sea of red" = the convalescent rash of dengue. Sparing of normal skin islands within the widespread erythematous rash during recovery. Pathognomonic appearance.
• Right-sided pleural effusion is more common than left (or bilateral) in dengue - the right pleural space is preferentially affected due to its drainage connections to the hepatic and retroperitoneal lymphatics affected by plasma leakage.

High-Yield Viva Points

• Q: Why does a second dengue infection cause worse disease than the first? A: Antibody-Dependent Enhancement (ADE). Non-neutralizing IgG from the first infection binds to the new serotype's virus particle. This complex binds Fc receptors on monocytes/macrophages, dramatically increasing viral entry and replication. The result is 100× more infected macrophages, a massive cytokine storm (TNF-α, IL-8, IFN-γ), complement activation, and endothelial permeability - leading to DHF/DSS.
• Q: Why is hematocrit rising if the patient has plasma leakage? A: Plasma (the liquid part of blood) leaks OUT of capillaries, but red blood cells (which are too large to cross damaged endothelium) stay behind. The red cells now occupy a larger proportion of a smaller blood volume → hematocrit (% of blood that is red cells) RISES = hemoconcentration. It is a direct measure of plasma loss.
• Q: Why is aspirin specifically banned in dengue in children? A: Two reasons - (1) Antiplatelet effect worsens bleeding in thrombocytopenic dengue; (2) Reye's syndrome - aspirin given to children with viral illnesses can cause fatal hepatic failure + encephalopathy. This is specifically called out in WHO dengue guidelines.
• Q: Why must IV fluids be reduced in the recovery phase? A: Leaked plasma reabsorbs back from third spaces (pleural cavity, ascites) into the intravascular space. If IV fluids continue at the same infusion rate, the circulating volume suddenly becomes excessive → pulmonary edema and acute cardiac failure. The hematocrit FALLS as plasma re-enters (dilutional) - this fall is the signal to reduce fluid rate.
• Q: What is the Dengvaxia controversy? A: Dengvaxia was initially given to school children in the Philippines. In dengue-naive (seronegative) children, the vaccine acted as a "first infection" - leaving them with non-neutralizing antibodies. When they subsequently encountered natural dengue, ADE occurred and they developed severe dengue at higher rates than unvaccinated children. Mandatory pre-vaccination serology testing is now required.

12. COMMON DIAGNOSTIC MISTAKES